Geode Capital Management, LLC Abvc Biopharma, Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$0.62 - $9.1 $230 - $3,376
-371 Reduced 0.27%
139,282 $87,000
Q3 2022

Nov 14, 2022
BUY
$0.52 - $8.9 $46,663 - $798,668
89,738 Added 179.78%
139,653 $122,000
Q3 2021

Nov 12, 2021
BUY
$2.03 - $5.1 $101,327 - $254,566
49,915 New
49,915 $115,000

About ABVC BIOPHARMA, INC.

ABVC Quotes by TradingView
  • Ticker ABVC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,632,300
  • Market Cap $18.3M
  • Description
  • ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major dep...
More about ABVC
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email